Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$1.79M Buy
69,222
+13,956
+25% +$335K 0.26% 136
2017
Q2
$1.31M Buy
55,266
+17,505
+46% +$407K 0.19% 216
2017
Q1
$799K Sell
37,761
-5,011
-12% -$118K 0.16% 249
2016
Q4
$1.05M Sell
42,772
-9,758
-19% -$263K 0.25% 144
2016
Q3
$1.6M Sell
52,530
-5,644
-10% -$160K 0.34% 61
2016
Q2
$1.45M Buy
58,174
+33,491
+136% +$903K 0.35% 54
2016
Q1
$685K Sell
24,683
-9,624
-28% -$241K 0.18% 241
2015
Q4
$854K Sell
34,307
-10,573
-24% -$266K 0.24% 154
2015
Q3
$1.04M Buy
+44,880
New +$1.07M 0.24% 154

Other funds holding CVG

GAM Systematic's CVG Position: Q3 2017 in Review

GAM Systematic increased its Convergys (CVG) stake by 25% in Q3 2017, buying an estimated $335K and bringing the position to 69,222 shares worth $1.79M. The position accounts for 0.26% of the portfolio, ranked #136.

GAM Systematic first reported a position in CVG in Q3 2015 and has held it in 9 quarters since. 248 funds tracked by Wall St. Rank hold CVG as of Q3 2017.

  • GAM Systematic held 69,222 shares of Convergys worth $1.79M as of Q3 2017.
  • GAM Systematic bought 13,956 Convergys shares in Q3 2017, an estimated $335K.
  • Convergys made up 0.26% of GAM Systematic's portfolio in Q3 2017, its #136 holding.
  • GAM Systematic first reported a position in Convergys in Q3 2015 and has held it in 9 quarters since.
  • 248 funds tracked by Wall St. Rank held Convergys as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.